Clinical Research Services
Digital Research Services
Agile : the ability to quickly deploy studies, manage complexity, and enhance quality–and to do this within a strict regulatory environment.
Our objectives are to exceed expectations
We provide tools, knowledge and ressources
Quality and timing at affordable pricing
Our flexibility and experience in the pharmaceutical market, while always maintaining a cost-conscious approach, differentiates us from other CROs. We are able to respond to the changing requirements of the study without time-consuming CRO bureaucracy and delayed deliverables.
Years of Experience
To maximize return on R&D investments, strengthen market position and maximize efficiencies, Popsicube-Fovea and our Project Manager should be involved as early as possible in the product lifecycle management to align expectations and fully understand your goals and objectives for your development plan. In addition, Popsicube-Fovea will use leading-edge technologies like eTools and data analytic platforms.
Popsicube-Fovea will continuously improve standard processes and establish other innovative approaches to bring business value, realize cost reductions and ensure shorter development cycles.
Our diverse and experienced Board of Directors provides ongoing counsel and oversight while ensuring the company adds value and acts in the best interests of its clients.
Fabrice has over 20 years of experience in drug development for a US contract research organization (CRO) as well as for French and global pharmaceutical companies. Fabrice also acts as International Informatic Project Manager for a pharmaceutical firm in charge of the implementation of clinical e-Tools. In 2004, he launched POPSI CUBE, to carry out a variety of clinical development projects with large and small international pharmaceutical or medtech customers. Fabrice has a Mphil in Energetic Physiology and a Masters’ degree in statistics applied to medicine.
Sylvie has more than 20 years of expertise in the pharmaceutical industry. She worked in laboratories and Contract Research Organisations (CRO) in clinical research with effective management of teams and individuals, both in matrix and structured environments. - International experience. - Gradual and regular promotions: CRA, Clinical Project Manager, GCP officer, Purchasing Manager, Methods & Training Manager, Head of Corporate Operations at Pharmacia (acquired by Pfizer).
Guy brings over 30 years of pharmaceutical and drug development industry experience in both large and start-up companies. He is currently CEO of Popsi Cube, Inc., our North American affiliate. Previously, he served as VP, Operations at Kayentis, a clinical data capture company. Mr. Maestre was also CEO of Novactyl and PhenoTech, two early stage biotech companies where he led the funding and early drug product development activities for the companies. Prior to that, he held positions of increasing responsibilities within Wyeth Pharma, including the offices of VP, Strategic Planning.
The following are just some of the positive things that our clients or partners are saying about us.
« To increase the quality management of patients treated by chemotherapy, we asked Popsicube team to develop a specific solution to follow, record and analyze the chemotherapy induced toxicities. This application is shared in our department and it allows also patients to visualize their own care program through a secure web access. Popsicube really understood the context of cancer patients management and integrated the complexity of our needs due to both chemotherapy treatment and lot of actors (physicians, nurses, assistants...) . »
« We were searching a solution to manage medical data and pictures for our prescribers, Popsicube proposed a tailor-made, professional and user-frendly solution which follow all the medical, technical and regulatory requirements (CNIL et CNOM) »
« Popsicube is for Bluelinea the perfect partner to evaluate the needs of pharmaceutical companies about record and treatment of clinical data. Popsicube well knows the project management in pharmaceutical environment and create and develops specific applications. With these sofwares, the medical directors or clinical operations directors are able to better follow there planning and ressources with key indicators. »
Thank you for having assumed this statistical analysis finalization in a record time and congratulations to all your team for this special effort. I personally express to you and your team my deep appreciation. Sincerely,
I’m sending you my sincere thanks for your willingness to sacrifice your weekend and for all the work you have done with your team since Friday.It is a great relief for all of us.